0J5Q Stock Overview
Develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0J5Q from our risk checks.
Hologic, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$78.69 |
| 52 Week High | US$84.33 |
| 52 Week Low | US$68.17 |
| Beta | 0.99 |
| 11 Month Change | -3.36% |
| 3 Month Change | -3.27% |
| 1 Year Change | 9.79% |
| 33 Year Change | 5.76% |
| 5 Year Change | 59.97% |
| Change since IPO | 81.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0J5Q | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -1.3% | 7.7% | -0.4% |
| 1Y | 9.8% | -2.1% | 5.6% |
Return vs Industry: 0J5Q exceeded the UK Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: 0J5Q exceeded the UK Market which returned 5.6% over the past year.
Price Volatility
| 0J5Q volatility | |
|---|---|
| 0J5Q Average Weekly Movement | 2.5% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0J5Q has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0J5Q's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 6,990 | Steve MacMillan | www.hologic.com |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.
Hologic, Inc. Fundamentals Summary
| 0J5Q fundamental statistics | |
|---|---|
| Market cap | US$18.26b |
| Earnings (TTM) | US$701.50m |
| Revenue (TTM) | US$3.99b |
26.1x
P/E Ratio4.6x
P/S RatioIs 0J5Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0J5Q income statement (TTM) | |
|---|---|
| Revenue | US$3.99b |
| Cost of Revenue | US$1.57b |
| Gross Profit | US$2.42b |
| Other Expenses | US$1.71b |
| Earnings | US$701.50m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.02 |
| Gross Margin | 60.58% |
| Net Profit Margin | 17.59% |
| Debt/Equity Ratio | 51.4% |
How did 0J5Q perform over the long term?
See historical performance and comparison